James Omel
- Hematology top 1%
- Oncology top 5%
- Molecular Biology
- Genetics top 5%
- Public Health, Environmental and Occupational Health
- Co-authors
- Kelly GodbyLuciano J. CostaShaji KumarElizabeth E. BrownIlene BrillSergio GiraltStephen W. CrawfordWael Saber
- Topics
- Multiple Myeloma Research and Treatments (19 papers)Protein Degradation and Inhibitors (10 papers)Cancer Treatment and Pharmacology (6 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
James Omel
26 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Hematology 915
- Oncology 540
- Molecular Biology 440
- Genetics 188
- Public Health, Environmental and Occupational Health 137
Countries citing papers authored by James Omel
This map shows the geographic impact of James Omel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Omel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Omel more than expected).
Fields of papers citing papers by James Omel
This network shows the impact of papers produced by James Omel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Omel. The network helps show where James Omel may publish in the future.
Co-authorship network of co-authors of James Omel
This figure shows the co-authorship network connecting the top 25 collaborators of James Omel. A scholar is included among the top collaborators of James Omel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Omel. James Omel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 71 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 146 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 133 | |
| 11 | 7 | |
| 12 | 11 | |
| 13 | 61 | |
| 14 | 12 | |
| 15 | 2 | |
| 16 | 211 | |
| 17 | 221 | |
| 18 | 252 | |
| 19 | 15 | |
| 20 | 61 |
About James Omel
James Omel is a scholar working on Hematology, Oncology and Transplantation, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (10 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Hematology (915 citations), Oncology (540 citations) and Genetics (188 citations). James Omel has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kelly Godby, Luciano J. Costa, Shaji Kumar, Elizabeth E. Brown, Ilene Brill, Sergio Giralt, Stephen W. Crawford, Wael Saber, Navneet S. Majhail and Paul J. Orchard. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.